Czech Republic One of the very first former-communist European states to attain a successful economic transition, the Czech Republic today puts across a compelling argument for being regarded as one of the regional leaders in pharmaceuticals, healthcare and life sciences. In the Czech Republic we have the right balance between sophisticated…
Pfizer Rodrigo Puga, the recently appointed general manager of Pfizer Mexico, documents his strategic priorities to further strengthen the company’s performance in Mexico and consolidate Pfizer’s leadership within the Mexican market and the overall healthcare eco-system of the country. You were appointed country manager of Pfizer Mexico in June 2016, while…
Switzerland Heike Behn, reveals how her number one priority at Nordic Pharma Switzerland, the group’s’newest affiliate, is to develop their rheumatology business, building on their gynecology platform; how the speed with which they can approach the customer is a major competitive advantage for the company; and how Switzerland´s approval process, when…
Mexico General Manager of Merck Mexico, Pedro Galvis, showcases the strategic importance of the Mexican affiliate within Merck’s global network and explains the importance of public-private partnerships in enhancing patient access and treatment in emerging markets. “The Mexican affiliate is a strong contributor to the region’s revenues and one of…
Singapore Toshifumi Tada, Managing Director of MT Pharma, shares the significance of Singapore to their presence in the region, the strategic direction of the company to “open up the future,” as well as their partnership efforts with local communities. With the company recently establishing its legal entity in Singapore in April…
Mexico. B. Braun Paulina Escobedo, general manager of B. Braun Medical Mexico, provides insights into the impressive development of this division since it was set up in the country in 2011, while the company will introduce its pharma product portfolio in Mexico in the upcoming months. She also documents the comprehensive partnership approach…
Mexico The university spin-off UDIBI continues its unstoppable ascension: after being recently recognized by Cofepris, Mexico’s sanitary agency, as an authorized laboratory to assess biotech treatments entering the Mexican market, UDIBI has no started to develop its own, innovative compounds. Sonia Mayra Peréz Tapia, executive director of UDIBI, highlights the ambitious…
Ireland Una Halligan, Chairperson of the Expert Group on Future Skills Needs (EGFSN), outlines the findings of its recently published report on the biopharma industry, the advantages Ireland can offer the global biopharma industry, and her thoughts on the importance of open communication and collaboration between industry and the educational sector.…
Mexico Alexis Serlin, country president of Novartis Mexico and president of CANIFARMA, the industry chamber that brings together multinational and local drug manufacturers, explains how the pharmaceutical industry in Mexico aims to be recognized as a strategic sector by both the Ministries of Health and Economy. He highlights Novartis Mexico’s leadership in…
Mexico The General Directors of Rayere explain how the historical Mexican pharma company has been leveraging its outstanding manufacturing capacity and product development expertise to become a thriving and reputed player in the patented segment, while the company now envisions to bring its high-quality quality products to international markets. Rayere boasts…
Singapore Mundipharma’s president of Asia Pacific, Latin America, and the Middle East and Africa, Raman Singh defines the underlying drivers behind the company’s explosive growth, while sharing his insights on what it takes for pharma companies to truly succeed in modern-day emerging markets. He also elaborates on Mundipharma’s recent decision to…
Mexico Carlos Abelleyra Cordero, CEO Spanish Latin America of Aspen Labs, describes the rapid development of Aspen’s operational capacity throughout the region, in line with the company’s ambition to ultimately establish itself as the commercial partner of choice of big pharma companies in Latin America. He also documents Aspen’s focus on…
See our Cookie Privacy Policy Here
